BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Credit Suisse maintains outperform on Sun Pharmaceutical Industries
Halol facility operating at less than 50 per cent of its capacity. Chances of a warning letter is low at Halol. The company can recover 40-50 per cent of the lost sales.